News - Merck Serono


Current filters:

Merck Serono

Popular Filters

64 to 70 of 70 results

F-Star and Merck Serono in up to 492 million-euro collaboration on novel targeted biologics


Austrian biotech firm F-Star GmbH has entered into a research, license and commercialization agreement…

BiotechnologyF-StarLicensingMerck KGaAMerck SeronoPharmaceuticalResearch

Merck Serono in deal with Affectis Pharma to develop oral neurodegenerative disease drugs


Switzerland based Merck Serono, a division of Germany’s Merck KGaA (MRK: DE), has entered into a…

Affectis PharmaceuticalsLicensingMerck KGaAMerck SeronoNeurologicalPharmaceuticalResearch

UK’s NICE recommends naftidrofuryl oxalate for symptoms of peripheral arterial disease


The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance recommending…

Cardio-vascularEuropeMerck SerononaftidrofurylPharmaceuticalPraxilenePricingRegulation

Merck KGaA US units agree $44.3 million settlement with DoJ; Ranbaxy faces up to $1 billion fine?


Four US subsidiaries of German drug major Merck KGaA (MRK: DE) - Serono Laboratories, EMD Serono, Merck…

LegalMerck KGaAMerck SeronoNorth AmericaPharmaceuticalRanbaxy LaboratoriesRebif

64 to 70 of 70 results

Back to top